Long
Long
Long 
W
Meta Platforms: The Next two Trillion-Dollar AI WinnerHello,
Meta Platforms, Inc. is one of the world’s most dominant digital ecosystems, operating Facebook, Instagram, WhatsApp, and Messenger under its Family of Apps (FoA) segment, while simultaneously building the next frontier of computing through Reality Labs (RL), which focuses on virtual and augmented reality hardware, software, and immersive experiences. Founded in 2004 and headquartered in Menlo Park, California, the company has evolved into the backbone of global digital communication and advertising.
Financial performance has been exceptionally strong. For the full year 2024, total revenue rose to USD 164.50B from USD 134.90B in 2023, reflecting powerful ad demand and platform engagement. Net income surged to USD 62.36B (2023: USD 39.10B), while EPS climbed to USD 24.61 from USD 15.19—a clear signal of rising profitability and capital efficiency. The balance sheet remains robust, with assets at USD 276.05B against liabilities of USD 93.42B. Even with total debt increasing to USD 49.77B, leverage remains conservative relative to the company’s cash generation capacity.
Momentum continued into Q3 2025. Revenue grew 26% year-over-year to USD 51.24B, supported by resilient advertising performance. Operating income increased to USD 20.54B, maintaining an impressive 40% operating margin despite cost pressures. The quarter included a one-off USD 15.93B tax charge tied to the One Big Beautiful Bill Act, which temporarily compressed net income to USD 2.71B and diluted EPS to USD 1.05. Excluding this one-time hit, underlying profitability remains very strong.
Meta’s competitive strengths are broad and durable. Its global reach across billions of users creates a social graph unmatched by any competitor. Its advertising engine—powered by proprietary data, high-performance AI models, and in-house silicon—continues to set the industry standard. The rapid rise of Reels demonstrates the company’s rare ability to compete with and neutralize emerging threats at scale. Reality Labs, although loss-making, places Meta at the front of the next computing paradigm with early leadership in VR through the Quest ecosystem.
Challenges exist: regulatory scrutiny, an aging Facebook demographic, persistent Reality Labs losses, and cultural shifts in online engagement. Yet these risks are strategic rather than existential. Meta’s size, cash flow, and technical depth give it exceptional resilience.
The company’s clearest upside lies in AI monetization. It is now embedding advanced AI assistants across WhatsApp, Instagram, and Messenger—turning its communication tools into personalized commerce and service hubs. AI-driven ad automation is increasing conversion efficiency for businesses, enhancing Meta’s pricing power. For creators, AI-powered editing, content generation, and virtual production tools can unlock new subscription-based business lines. WhatsApp Business is becoming a gateway for “AI employees” for SMEs, enabling Meta to charge for customer support and workflow automation at global scale. AI-enhanced discovery on Instagram and Facebook is already boosting engagement and ad inventory, while AI-powered commerce features open new revenue streams.
Meta is transitioning from a pure social media company into a multi-layered AI-first platform with unmatched global distribution. Revenue growth, margin resilience, and AI-driven monetization point to a business with accelerating earnings power. With strong fundamentals, powerful cash flows, and clear catalysts in AI integration, advertising automation, and WhatsApp monetization, the long-term upside remains compelling.
Strong Buy: Meta offers one of the most attractive risk-reward profiles in the large-cap tech universe. Its scale, AI capabilities, and monetization runway position it as a cornerstone long-term compounder with significant re-rating potential as AI-enabled services mature.
Medium term target: $ 840 
Long
Education
Short
Long 
Long
Long
Long
Long
NVO USThe decline in Novo Nordisk shares is not the result of a single factor, but rather the result of a complex set of fundamental issues: weakening financial performance, loss of competitive advantage in key products, and increased strategic risks.
While negative data on Eli Lilly's weight loss pill in August 2025 triggered a temporary optimistic rebound in NVO shares, it failed to reverse the overall downward trend caused by the company's deeper structural problems.
Now, in order:
Operating and Financial Results
Sales and operating profit growth forecasts for 2025 have been lowered twice; Q3 2025 results below expectations
Operating margin fell to 41.7% from 44.7% (YoY), gross margin decreased to 81.0% from 84.6%
Free cash flow declined 11% due to a sharp increase in capital expenditures
Competitive pressure:
Superiority of Eli Lilly products.
Zepbound (Eli Lilly) demonstrates greater effectiveness in weight loss (20.2% vs. 13.7% for Wegovy); Mounjaro overtook Ozempic in diabetes sales.
NVO's CagriSema failed to meet expectations in clinical trials.
Companies such as Viking Therapeutics, Altimmune, Roche, and Amgen are developing promising anti-obesity drugs, threatening the Novo Nordisk-Eli Lilly duopoly.
The company recently agreed to set a "maximum fair price" for Medicare under the Inflation Reduction Act.
As a result of the deal, the price of Wegovy for certain patient categories is also expected to drop to $149 per month, compared to the current starting price of $1,349. Such a sharp price reduction will directly impact revenue and profits.
Novo Nordisk's share of the US GLP-1 market fell to 43%, while Eli Lilly's grew to 57%.
To protect profitability, Maziar's new CEO, Mike Dusdar, initiated stringent cost-cutting measures, including a hiring freeze, layoffs, and a 23.8% reduction in R&D spending. While this may support cash flow in the short term, this strategy raises concerns about long-term innovation. Eight R&D projects were terminated, potentially slowing the market launch of promising next-generation drugs such as CagriSema and oral semaglutide.
NVO shares attempted a reversal around $60, but then this figure became a mirror level, and investors sold en masse from this price, which is certainly concerning. The chart shows volumes around $60. Be that as it may, the price is now below $50, and we can see the market trying to catch a low, trying to cling to any level. We're expecting a lower price. 
Short
Long
NVIDIA Turn consolidation phase In Weekly Time frame“Chip maker? More like dip maker today.”
#NVIDIA
Trend / Momentum
The stock is in a consolidation phase and range-bound lately, not in a strong runaway uptrend. However, RSI is around neutral (~52), indicating neither overbought nor oversold conditions.
Support & Resistance Levels
Support: Key support around $175–$185.
Resistance: Key resistance near $208–$220, as per recent weekly analysis marked on the chart.
Bullish to neutral overall:
Technicals suggest no runaway rally at the moment, but the long-term trend remains constructive. If NVDA breaks above $229 with volume, it could signal a strong bullish leg. On the downside, a weekly close below $175 may put pressure on the stock and trigger further weakness toward Target-1 or consolidation.
Disclaimer
High Risk Investment
Trading or investing in assets like crypto, equity, or commodities carries high risk and may not suit all investors.
Analysis on this channel uses recent technical data and market sentiment from web sources for informational and educational purposes only, not financial advice. Trading involves high risks, and past performance does not guarantee future results. Always conduct your own research or consult a SEBI-registered advisor before investing or trading.
This channel, Render With Me, is not responsible for any financial loss arising directly or indirectly from using or relying on this information. Short 
